ENTX · NASDAQ · Biotechnology

Entera Bio (ENTX)

Develops oral peptide therapies through its N-Tab delivery platform.

$2.85
After-hours close−0.13 (−4.52%)
At close$2.99(+0.84%)

13F · 13D/G · Form 4

Institutions6.20%10.73M shares
28 holders · as of Jun 30, 2026
Insiders1.32%2.28M shares
10 holders · as of Aug 7, 2026
Strategic holders7.08%12.25M shares
1 holder · as of Aug 4, 2026
Other85.40%147.88M shares
remainder

173.14M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (173.14M in the company's Sep 23, 2026 report, 49.29M elsewhere); stakes use the report.

13F · 13D/G · Form 4

HolderStakeSharesDate
TCG Crossover GP III, LLCStrategic
7.08%12.25Mfiled Aug 4, 2026
Biotechnology Value Fund L PInstitution
5.30%9.17Mfiled Aug 4, 2026
Knoll Capital Management, LLCInstitution
3.40%5.88Mas of Jun 30, 2026
BVF Inc/ILInstitution
1.40%2.43Mas of Jun 30, 2026
Miranda Jayne ToledanoInsiderdirector, officer: Chief Executive Officer
0.49%847,135filed Jul 16, 2026
Siren, L.L.C.Institution
0.43%736,457as of Jun 30, 2026
Renaissance Technologies LLCInstitution
0.21%368,847as of Jun 30, 2026
Gerald M. LiebermanInsiderdirector
0.20%338,454filed Jan 2, 2026
Parkman Healthcare Partners LLCInstitution
0.16%274,497as of Jun 30, 2026
PNC Financial Services Group, Inc.Institution
0.16%273,031as of Jun 30, 2026
Sean EllisInsiderdirector
0.12%208,132filed Aug 7, 2026
Seven Fleet Capital Management LPInstitution
0.11%191,354as of Jun 30, 2026
Gregory BurshteinInsiderofficer: Chief of R&D
0.11%189,033filed May 8, 2026
Dana Yaacov-GarbeliInsiderofficer: Chief Financial Officer
0.10%171,441filed May 8, 2026
Hillel GalitzerInsiderofficer: Chief Operating Officer
0.09%163,566filed May 8, 2026
Haya TaitelInsiderdirector
0.07%119,269filed Aug 7, 2026
Yonatan MalcaInsiderdirector
0.06%100,231filed Aug 7, 2026
Gerald M. OstrovInsiderdirector
0.04%75,657filed Jan 2, 2026
Hightower Advisors, LLCInstitution
0.04%74,573as of Jun 30, 2026
HRT Financial LPInstitution
0.04%72,486as of Jun 30, 2026
Geno J. GermanoInsiderdirector
0.04%65,014filed Aug 7, 2026
Schonfeld Strategic Advisors LLCInstitution
0.03%58,871as of Jun 30, 2026
Two Sigma Securities, LLCInstitution
0.03%48,593as of Jun 30, 2026
Signature Estate & Investment Advisors LLCInstitution
0.03%47,328as of Jun 30, 2026
JPMorgan Chase & CoInstitution
0.02%40,883as of Jun 30, 2026

13F, as of Jun 30, 2026

28 holders · 10.73M shares · 7 new positions · 15 increased · 6 reduced · 6 closed

HolderShares% outstandingChg q/qFiled
Knoll Capital Management, LLC5.88M3.40%0Sep 10, 2026
BVF Inc/IL2.43M1.40%+2.43MnewAug 14, 2026
Siren, L.L.C.736.5K0.43%+736.5KnewAug 13, 2026
Renaissance Technologies LLC368.8K0.21%−104.6KAug 13, 2026
Parkman Healthcare Partners LLC274.5K0.16%−14.2KAug 14, 2026
PNC Financial Services Group, Inc.273.0K0.16%+263.0KAug 7, 2026
Seven Fleet Capital Management LP191.4K0.11%−14.2KAug 17, 2026
Hightower Advisors, LLC74.6K0.04%+37.7KAug 5, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Opko Health, Inc.8.10%3.69M13GApr 2, 2025
TCG Crossover GP III, LLC7.10%12.25M13GAug 4, 2026
Biotechnology Value Fund L P5.30%9.17M13DAug 4, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Mar 9, 2026
Geno J. Germanodirector
Purchase20,000$1.3040,000
Mar 5, 2026
Sean Ellisdirector
Purchase10,000$1.23188,098
Feb 9, 2026
Sean Ellisdirector
Purchase18,000$1.24178,098
Feb 10, 2026
Geno J. Germanodirector
Purchase20,000$1.490
Feb 10, 2026
Haya Taiteldirector
Purchase7,500$1.480
Dec 29, 2025
Miranda Jayne Toledanodirector, officer: Chief Executive Officer
Purchase11,000$1.81426,575

House and Senate disclosures

Not reported.